What is Curative Biotechnology Inc?
, a biopharmaceutical company, focuses on identifying, in licensing, and developing therapeutic drug candidates for rare disease indications.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biopharmaceutical company, focuses on identifying, in licensing, and developing therapeutic drug candidates for rare disease indications. It develops Metformin Reformulation to treat intermediate dry macular degeneration and geographic atrophy; IMT504, a novel immunotherapy to treat late-stage rabies; and CUBT906, a fully humanized CD56 monoclonal antibody carrying a cytotoxic drug conjugate directly to the tumor site to kill the tumor by inhibiting tumor growth and migration of the tumor. The company is listed on the NYSE MKT in USA, operating in the Healthcare sector, with a market capitalisation of 5.34M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.